ArriVent Posts Wider Loss in Fiscal Q2
ArriVent BioPharma, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $30.68
+16% in 7d after detection
Post-detection moves
1h
—
1d
+4.1%
3d
+2.2%
7d
+16%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS